Schedule 13G ownership disclosure

RECURSION PHARMACEUTICALS INC CL A

Security class unavailable · CUSIP: 75629V104

Event date: 2024-06-28

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
15,384,615
Percent of class
5.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-078315
Form type
SC 13G
Filer
RA CAPITAL MANAGEMENT, L.P.
CIK
CIK 1346824
Filed
Jul 08, 2024
Reporting period
Jun 28, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub